Immunomedics Common
|
31.7 |
$2.2B |
|
26M |
85.03 |
Mirati Therapeutics Common
|
10.2 |
$721M |
|
4.3M |
166.05 |
Horizon Therapeutics Common
|
8.4 |
$594M |
|
7.7M |
77.68 |
Iovance Biotherapeutics Common
(IOVA)
|
4.5 |
$314M |
|
9.5M |
32.92 |
Ascendis Pharma Sponsored ADR
(ASND)
|
3.9 |
$278M |
|
1.8M |
154.32 |
Myokardia Common
|
3.7 |
$257M |
|
1.9M |
136.33 |
Argenx Se Sponsored ADR
(ARGX)
|
3.4 |
$237M |
|
903k |
262.52 |
Sarepta Therapeutics Common
(SRPT)
|
3.3 |
$235M |
|
1.7M |
140.43 |
Arena Pharmaceuticals Common
|
3.3 |
$232M |
|
3.1M |
74.79 |
Amicus Therapeutics Common
(FOLD)
|
2.2 |
$153M |
|
11M |
14.12 |
Acceleron Pharma Common
|
2.2 |
$152M |
|
1.4M |
112.53 |
Biomarin Pharmaceutical Common
(BMRN)
|
1.9 |
$133M |
|
1.8M |
76.08 |
Mersana Therapeutics Common
(MRSN)
|
1.8 |
$127M |
|
6.8M |
18.62 |
Madrigal Pharmaceuticals Common
(MDGL)
|
1.5 |
$106M |
|
890k |
118.73 |
Deciphera Pharmaceuticals Common
|
1.3 |
$93M |
|
1.8M |
51.30 |
Adaptimmune Therapeutics Sponsored ADR
(ADAP)
|
1.2 |
$88M |
|
11M |
7.98 |
Karyopharm Therapeutics Common
(KPTI)
|
1.2 |
$88M |
|
6.0M |
14.60 |
Constellation Pharmaceuticals Common
|
1.2 |
$87M |
|
4.3M |
20.26 |
Adverum Biotechnologies Common
|
1.2 |
$82M |
|
8.0M |
10.30 |
Trillium Therapeutics Common
|
1.1 |
$78M |
|
5.5M |
14.21 |
Kura Oncology Common
(KURA)
|
1.1 |
$75M |
|
2.4M |
30.64 |
Cymabay Therapeutics Common
|
1.1 |
$75M |
|
10M |
7.24 |
Uniqure Nv Common
(QURE)
|
0.9 |
$65M |
|
1.8M |
36.83 |
Pmv Pharmaceuticals Common
(PMVP)
|
0.8 |
$58M |
|
1.9M |
31.12 |
Relmada Therapeutics Common
(RLMD)
|
0.8 |
$56M |
|
1.5M |
37.62 |
Iveric Bio Common
|
0.6 |
$41M |
|
7.3M |
5.64 |
Athenex Common
|
0.6 |
$40M |
|
3.3M |
12.10 |
Marinus Pharmaceuticals Common
|
0.5 |
$39M |
|
3.0M |
12.85 |
Xenon Pharmaceuticals Common
(XENE)
|
0.4 |
$31M |
|
2.8M |
11.07 |
Cue Biopharma Common
(CUE)
|
0.4 |
$28M |
|
1.9M |
15.05 |
Altimmune Common
(ALT)
|
0.4 |
$26M |
|
2.0M |
13.20 |
Amarin Corp Sponsored ADR
(AMRN)
|
0.4 |
$25M |
|
6.0M |
4.21 |
Retrophin Common
|
0.3 |
$25M |
|
1.3M |
18.46 |
Relay Therapeutics Common
(RLAY)
|
0.3 |
$21M |
|
500k |
42.59 |
Avadel Pharmaceuticals Sponsored ADR
|
0.3 |
$21M |
|
4.2M |
5.04 |
Rapt Therapeutics Common
(RAPT)
|
0.3 |
$19M |
|
575k |
32.20 |
Black Diamond Therapeutics Common
(BDTX)
|
0.3 |
$18M |
|
603k |
30.23 |
Zogenix Common
|
0.2 |
$16M |
|
875k |
17.93 |
Avidity Biosciences Common
(RNA)
|
0.2 |
$15M |
|
545k |
28.15 |
Therapeutics Acquisition Corp Common
|
0.2 |
$14M |
|
1.0M |
14.38 |
Genocea Biosciences Common
(GNCAQ)
|
0.2 |
$12M |
|
5.1M |
2.29 |
Iteos Therapeutics Common
(ITOS)
|
0.2 |
$11M |
|
460k |
24.67 |
Fennec Pharmaceuticals Common
(FENC)
|
0.1 |
$10M |
|
1.7M |
6.06 |
Bctg Acquisition Corp Common
|
0.1 |
$8.7M |
|
800k |
10.84 |
Alimera Sciences Common
|
0.0 |
$2.0M |
|
416k |
4.86 |
Kymera Therapeutics Common
(KYMR)
|
0.0 |
$1.6M |
|
49k |
32.31 |